Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
Clinical trial NCT01714726 · COMPLETED
Trial details
- NCT number
- NCT01714726
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-05-20
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.